PureTech gives up on re­gain­ing con­trol of Gele­sis and its weight loss pill

PureTech is call­ing off its pro­posed all-stock buy­out of weight loss-fo­cused spin­out Gele­sis, choos­ing in­stead to “fo­cus on oth­er strate­gic busi­ness ini­tia­tives.”

“The trans­ac­tion was …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER